PG

Panduranga Gali

Active Director Director DIN 11401931
DIN 11401931 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value •••• Premium profile

About Panduranga Gali

Data last updated:

Panduranga Gali is a Director at Aleta Pharmaceuticals Private Limited (since 2026). The company operates in Pharma. Aleta Pharmaceuticals Private Limited reported revenue of ₹2.58 Cr (FY 2025).

DIN 11401931
Primary Designation Director
Industry Pharma
First Appointment 06 Jan 2026
Largest company Aleta Pharmaceuticals Private Limited · ₹2.58 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jan 2026₹2.58 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Aleta Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Panduranga Gali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Panduranga Gali

Panduranga Gali currently holds 1 directorship: Aleta Pharmaceuticals Private Limited (Director, since 06 Jan 2026, revenue ₹2.58 Cr (FY 2025)).

Panduranga Gali was first appointed on 06 Jan 2026 as Director at Aleta Pharmaceuticals Private Limited.

The current boards of Panduranga Gali's companies include Ajay Kumar Donthula (Aleta Pharmaceuticals Private Limited), Damodarsinggh (Aleta Pharmaceuticals Private Limited), Malla Reddy Sripathi (Aleta Pharmaceuticals Private Limited), Meena Bagdwal (Aleta Pharmaceuticals Private Limited), Yakaiah Ambati (Aleta Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available